Education
About Us
Working with TipRanks
Follow Us
Karen Prange Insider Profile
11 Followers
Karen Prange, SVP&Pres, Uro & Pelvic Health at Boston Scientific, holds 23.23K shares in Atricure (Ticker: ATRC), holds 0.00 shares in Nevro Corp (Ticker: NVRO), holds 39.74K shares in Embecta Corporation (Ticker: EMBC).
Karen Prange Boston Scientific (BSX)SVP&Pres, Uro & Pelvic Health
Boston Scientific (BSX)
SVP&Pres, Uro & Pelvic Health
Ranked #74,562 out of 102,551 Corporate Insiders
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-16.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Karen Prange holds in companies
Most Profitable Insider Trade
The most profitable trade made by Karen Prange
Karen Prange's Trading History
Boston Scientific
Mar 08, 2016
SVP&Pres, Uro & Pelvic Health
Uninformative Sell
254.68K
$5.61M
Henry Schein
Mar 06, 2018
EVP&CEO Gl.AH.Med.Den.Sur.Grp
Uninformative Buy
―
$4.35M
Atricure
May 21, 2025
Director
Uninformative Buy
―
$679.68K
Nevro Corp
Apr 03, 2025
―
Uninformative Sell
―
$0.00
Cantel Medical
Jul 31, 2020
―
Uninformative Buy
―
$155.52K
Viewray
Jul 21, 2023
Director
Informative Sell
8.31K
$105.59
Embecta Corporation
Feb 14, 2025
Director
Uninformative Buy
―
$388.69K
List of latest transactions for each holding click on a transaction to see Karen Prange's performance on stock
You May Also Like
Karen Prange insider profile FAQ
What is the percentage of profitable transactions made by Karen Prange?
The percentage of profitable transactions made by Karen Prange is 50%.
What is the average return per transaction made by Karen Prange?
The average return per transaction made by Karen Prange is -16.60%.
What stocks does Karen Prange hold?
Karen Prange holds: BSX, HSIC, ATRC, NVRO, CMD, VRAYQ, EMBC stocks.
What was Karen Prange’s latest transaction?
Karen Prange latest transaction was an Uninformative Buy of ―.
What was Karen Prange's most profitable transaction?
Karen Prange’s most profitable transaction was an Informative Sell of ATRC stock on June 12, 2023. The return on the trade was 53.20%.
What is Karen Prange's role in Boston Scientific?
Karen Prange's role in Boston Scientific is SVP&Pres, Uro & Pelvic Health.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.